Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity

Gynecologic Oncology

Volumn 90, Issue 2, 2003, Pages 318-324

  Lopata, Alex ^a   Agresta, Franca ^a   Quinn, Michael A ^a,b   Smith, Catherine ^a   Ostor, Andrew G ^a   Salamonsen, Lois A ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Endometrial adenocarcinoma; Gelatinases; Matrix metalloproteinases; Sensitivity and specificity determination; Uterine lavage

Indexed keywords

BIOLOGICAL MARKER; GELATIN; GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CELL FREE SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; FEMALE; HISTOLOGY; HUMAN; LAVAGE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METHODOLOGY; MYOMETRIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SUPERNATANT; UTERUS; UTERUS CAVITY; ZYMOGRAPHY;

EID: 0042123774     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00328-7     Document Type: Article

References (20)

1. American Cancer Society. Cancer facts & figures 2001: the American Cancer Society, 2001.
2. North American Association. Highlights of cancer in North America, 1991-1995. Vol. 1 and 2, 1999.
3. Australian Institute of Health and Welfare. Cancer in Australia 1991-1994 (with projections to 1999), [ http://www.aihw.gov.au/publications/health.html .] 1999.
4. Homesley H., Zaino R. Endometrial cancer prognostic factors . Semin Oncol. 21:1994;71-78.
5. Brooks S. A review of screening and early detection of endometrial cancer and use of risk assessment. J Assoc Acad Minor Phys. 8:1997;34-37.
6. Hulka B. Cancer screening. Degrees of proof and practical application. Cancer. 62:1988;1776-1780.
7. Ciatto S., Cecchini S., Bonardi R., Grazzini G., Mazzotta A., Zappa M. A feasibility study of screening for endometrial carcinoma in postmenopausal women by ultrasonography. Tumori. 81:1995;334-337.
8. Feldman S., Berkowitz R.S., Tosteson A.A. Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obste Gynecol. 81:1993;968-975.
9. Miller A.B. An epidemiological perspective on cancer screening. Clin Biochem. 28:1995;41-48.
10. Liotta L., Stetler-Stevenson W. Metalloproteinases and cancer invasion. Semin Cancer Biol. 1:1990;99-106.
11. Stetler-Stevenson W. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol. 9:1993;541-573.
12. Chambers A., Matrisian L. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 89:1997;1260-1270.
13. Takemura M., Azuma C., Kimura T., et al. Malignant cell-specific gelatinase activity in human endometrial-cancer. Cancer. 70:1992;147-151.
14. di Nezza L.A., Misajon A., Zhang J., et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer. 94:2002;1466-1475.
15. Moser T.L., Young T.N., Rodriguez G.C., Pizzo S.V., Bast R.C.J., Stack M.S. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer. 56:1994;552-559.
16. Zucker S., Lysik R., Zarrabi M., Moll U. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53:1993;140-146.
17. Davidson B., Goldberg I., Kopolovic J., et al. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix - clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol. 72:1999;380-386.
18. Kleiner D., Stetler-Stevenson W. Quantitative zymography - detection of picogram quantities of gelatinases. Anal Biochem. 218:1994;325-329.
19. Salamonsen L., Butt A., Hammond F., Garcia S., Zhang J. Production of endometrial matrix metalloproteinases but not their tissue inhibitors is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab. 82:1997;1409-1415.
20. Laird S., Dalton C., Okon M., Bunning R., Marshall R., Li T. Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma. J Reprod Fertil. 115:1999;225-232.